Amarin | AMRN - Assets

Amarin reported $908.3M in Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Assets Change
DBV Technologies DBVT:US USD 246.52M 1.6M
Alnylam Pharmaceuticals ALNY:US USD 3.55B 11.1M
Amarin AMRN:US USD 908.3M 64.93M
AstraZeneca AZN:LN USD 96.48B 2.3B
Biocryst Pharmaceuticals BCRX:US USD 550M 8.59M
Esperion Therapeutics ESPR:US USD 247.94M 64.89M
GlaxoSmithKline GSK:LN GBP 60.15B 167M
Halozyme Therapeutics HALO:US USD 1.84B 23.03M
Heron Therapeutics HRTX:US USD 271.95M 27.99M
Intercept Pharmaceuticals ICPT:US USD 553.71M 5.69M
IONIS PHARMACEUT IONS:US USD 2.53B 111.9M
JAZZ PHA JAZZ:US USD 10.84B 450.59M
Nektar Therapeutics NKTR:US USD 710.6M 70.41M
Neurocrine Biosciences NBIX:US USD 2.37B 225.3M
Novartis NOVN:VX USD 117.45B 1.01B
Teva Pharmaceutical Industries TEVA:US USD 44.01B 246M